Invention Grant
- Patent Title: Agent for treating synucleinopathy
-
Application No.: US16089536Application Date: 2017-03-31
-
Publication No.: US10709688B2Publication Date: 2020-07-14
- Inventor: Kohji Fukunaga , Hiroyuki Miyachi , Hiroaki Ishida , Shintaro Ban
- Applicant: TOHOKU UNIVERSITY , NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
- Applicant Address: JP Miyagi JP Okayama
- Assignee: Tohoku University,National University Corporation Okayama University
- Current Assignee: Tohoku University,National University Corporation Okayama University
- Current Assignee Address: JP Miyagi JP Okayama
- Agency: Foley & Lardner LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@140bb3a8
- International Application: PCT/JP2017/013742 WO 20170331
- International Announcement: WO2017/171053 WO 20171005
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/12 ; A61P25/28 ; A61P25/16 ; A61K9/00
Abstract:
This invention provides a pharmaceutical composition for treating or preventing synucleinopathy comprising a compound represented by formula (I), or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190125726A1 AGENT FOR TREATING SYNUCLEINOPATHY Public/Granted day:2019-05-02
Information query
